Welcome to LookChem.com Sign In|Join Free
  • or
(6S)-3-((2-chlorophenyl)thio)-6-(4-morpholinophenyl)-6-(thiophen-3-yl)piperidine-2,4-dione is a complex chemical compound featuring a piperidine ring with various substituents, including thio, chlorophenyl, morpholinophenyl, and thiophen moieties. Its intricate structure may confer potential pharmaceutical applications, allowing for interactions with a range of biological targets. Further research is required to elucidate its specific biological and pharmacological properties, as well as its synthesis and characterization for potential development.

1802977-61-2

Post Buying Request

1802977-61-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1802977-61-2 Usage

Uses

Used in Pharmaceutical Industry:
(6S)-3-((2-chlorophenyl)thio)-6-(4-morpholinophenyl)-6-(thiophen-3-yl)piperidine-2,4-dione is used as a potential pharmaceutical agent for its diverse structure, which may enable interactions with various biological targets. Its specific applications and effects would need to be determined through further studies and research.
Note: Since the provided materials do not specify any particular use for (6S)-3-((2-chlorophenyl)thio)-6-(4-morpholinophenyl)-6-(thiophen-3-yl)piperidine-2,4-dione, the above use is a general statement based on the potential of its complex structure for pharmaceutical applications. Further information would be needed to detail specific applications and reasons.

Check Digit Verification of cas no

The CAS Registry Mumber 1802977-61-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,8,0,2,9,7 and 7 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1802977-61:
(9*1)+(8*8)+(7*0)+(6*2)+(5*9)+(4*7)+(3*7)+(2*6)+(1*1)=192
192 % 10 = 2
So 1802977-61-2 is a valid CAS Registry Number.

1802977-61-2Downstream Products

1802977-61-2Relevant academic research and scientific papers

Cell Active Hydroxylactam Inhibitors of Human Lactate Dehydrogenase with Oral Bioavailability in Mice

Purkey, Hans E.,Robarge, Kirk,Chen, Jinhua,Chen, Zhongguo,Corson, Laura B.,Ding, Charles Z.,Dipasquale, Antonio G.,Dragovich, Peter S.,Eigenbrot, Charles,Evangelista, Marie,Fauber, Benjamin P.,Gao, Zhenting,Ge, Hongxiu,Hitz, Anna,Ho, Qunh,Labadie, Sharada S.,Lai, Kwong Wah,Liu, Wenfeng,Liu, Yajing,Li, Chiho,Ma, Shuguang,Malek, Shiva,O'Brien, Thomas,Pang, Jodie,Peterson, David,Salphati, Laurent,Sideris, Steve,Ultsch, Mark,Wei, Binqing,Yen, Ivana,Yue, Qin,Zhang, Huihui,Zhou, Aihe

, p. 896 - 901 (2016)

A series of trisubstituted hydroxylactams was identified as potent enzymatic and cellular inhibitors of human lactate dehydrogenase A. Utilizing structure-based design and physical property optimization, multiple inhibitors were discovered with 50 in a MiaPaca2 cell line. Optimization of the series led to 29, a potent cell active molecule (MiaPaca2 IC50 = 0.67 μM) that also possessed good exposure when dosed orally to mice.

LDHA ACTIVITY INHIBITORS

-

, (2018/12/13)

The invention provides compounds of formula (I), stereoisomers and pharmaceutically acceptable salts thereof: (I) wherein A1 to A4, R1 and RP are as defined herein. Such compounds are suitable for use in the treatment or prevention of diseases or conditions which are mediated by the activation of lactate dehydrogenase A (LDHA), for example cancer.

LDHA ACTIVITY INHIBITORS

-

, (2018/12/13)

The invention provides compounds of formula (I), stereoisomers, tautomers, pharmaceutically acceptable salts and prodrugs thereof: (I) wherein A1 to A6 and R1 to R4 are as defined herein. Such compounds are suit

PIPERIDINE-DIONE DERIVATIVES FOR USE AS CONTRACEPTIVES

-

, (2018/12/13)

The invention relates to a method of reducing sperm motility or of contraception in a subject, said method comprising the step of administering to said subject an effective amount of a compound of formula (I), a stereoisomer, tautomer, pharmaceutically ac

METHOD OF CONTROLLING LACTATE PRODUCTION WITH PIPERDINE-DIONE DERIVATIVES

-

Page/Page column 79-80; 241, (2015/11/10)

The invention provides novel compounds having the general formula: and tautomers and pharmaceutically acceptable salts thereof, wherein A1, A2, A3, A4, R1, R4, R5, R6, R7 and R8 are as defined herein, compositions including the compounds and methods of using the compounds.

PIPERIDINE-DIONE DERIVATIVES

-

Page/Page column 150, (2015/11/10)

The invention provides novel compounds having the general formula (I) and tautomers and pharmaceutically acceptable salts thereof, wherein A1, A2, A3, A4, R1, R4, R5, R6, R7 and R8 are as defined herein, compositions including the compounds and methods of using the compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1802977-61-2